22 November 2020 : Clinical Research
Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China
Wei Sun1ABCDEF, Hao Zhang1ABCDG*, Liang He2DE, Ting Zhang1BE, Zhihong Wang1BCD, Wenwu Dong1CDE, Yingling Jiang1EDOI: 10.12659/MSM.928391
Med Sci Monit 2020; 26:e928391
Supplementary Table 1 Characteristics and clinical features of 21 residual patients one by one.
| Patient number | Sex | Age | FNA (+) | Ablation position | Nodule size (before ablation) | TI-RADS | Nodule size (after ablation) | TI-RADS | Pathology | Interval days |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 27 | R | R | 2.6×1.1 | 4b | 2.8×1.3 | 5 | PTC | 30 |
| 2 | Female | 50 | R | R | 2.3×1.4 | 4a | 2.0×1.6 | 4b | PTC | 6 |
| 3 | Male | 31 | R | R | 0.9×0.8 | 4a | 1.9×1.6 | 4b | PTC | 17 |
| 4 | Female | 66 | R | R & L | 1.8×1.0 | 4a, 3 | 2.1×1.3 | 4b, 4a | PTC/PTC* | 37 |
| 0.5×0.6 | 0.9×0.6 | |||||||||
| 5 | Female | 32 | R & L | R & L | 3.6×2.5 | 4b, 4a | 2.6×2.1 | 4c, 4b | PTC/PTC | 9 |
| 1.2×1.6 | 1.4×1.0 | |||||||||
| 6 | Male | 46 | R | R | 3.6×2.1 | 4b | 5.2×3.5 | 4b | PTC | 365 |
| 7 | Female | 42 | R | R & L | 1.0×0.8 | 4a, 4a | 3.1×1.2 | 4b, 4b | PTC/PTC* | 10 |
| 0.6×0.4 | 2.7×1.2 | |||||||||
| 8 | Male | 44 | R | R & L | 2.1×1.6 | 4b, 3 | 2.3×1.6 | 4b, 4a | MTC/NG | 20 |
| 0.8×0.7 | 0.9×1.0 | |||||||||
| 9 | Female | 64 | R & L | R & L | 1.1×0.5 | 4b, 4a | 1.5×0.6 | 4c, 4a | PTC/PTC | 30 |
| 2.9×2.1 | 2.9×1.4 | |||||||||
| 10 | Male | 74 | L | L | 3.2×2.0 | 4a | 2.8×2.4 | 4a | PTC | 210 |
| 11 | Female | 51 | L | L | 2.5×1.8 | 4a | 2.6×1.6 | 4b | PTC | 368 |
| 12 | Female | 54 | L | L | 1.6×1.6 | 4b | 2.0×1.4 | 4b | PTC | 18 |
| 13 | Male | 34 | L | L | 3.9×2.2 | 4b | 1.9×1.8 | 4b | PTC | 30 |
| 14 | Female | 35 | R | R & L | 0.7×0.5 | 3, 4a | 1.0×1.3 | 4a, 4a | PTC/PTC* | 45 |
| 0.3×0.4 | 0.6×0.7 | |||||||||
| 15 | Female | 42 | L | L | 1.5×1.2 | 4a | 2.2×1.6 | 3 | PTC | 30 |
| 16 | Female | 26 | L | R & L | 1.5×1.0 | 4a,4b | 1.7×1.9 | 4a,4b | HD/PTC | 48 |
| 0.7×0.5 | 1.1×0.5 | |||||||||
| 17 | Female | 59 | R & L | R & L | 0.5×0.6 | 3,4a | 1.0×0.4 | 4a,4a | NG/PTC* | 60 |
| 0.5×0.4 | 1.1×0.8 | |||||||||
| 18 | Female | 48 | R | R & L | 1.7×1.3 | 4b, 3 | 2.5×1.8 | 4c, 3 | PTC/NG | 36 |
| 1.0×0.6 | 0.8×0.7 | |||||||||
| 19 | Female | 45 | R | R & L | 2.3×1.6 | 4a, 4a | 3.3×1.8 | 4b, 4a | PTC/PTC* | 20 |
| 0.7×0.4 | 1.7×0.9 | |||||||||
| 20 | Male | 29 | R | R | 1.6×1.2 | 4a | 1.8×1.1 | 4a | PTC | 16 |
| 21 | Female | 44 | R | R & L | 1.0×0.8 | 4a, 3 | 0.8×0.5 | 4b, 4a | PTC/PTC* | 180 |
| 0.4×0.4 | 0.6×0.5 | |||||||||
| FNA – fine needle ablation; TT – total thyroidectomy; R – right; L – right; PTC – papillary thyroid cancer; MTC – medullary thyroid cancer, NG – nodular goiter; HD – Hashimoto diseases. * Nodular goiter which pathological and FNA results. | ||||||||||